期刊
CARDIOVASCULAR RESEARCH
卷 117, 期 7, 页码 1732-1745出版社
OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvab172
关键词
Atrial fibrillation; Autonomic nervous system; Neurocardiology; Neuromodulation; Vagus nerve
资金
- NIH through the Common Fund's Stimulating Peripheral Activity to Relieve Conditions (SPARC) programme [OT2 OD023848]
- National Heart, Lung, and Blood Institute Ruth L. Kirschstein Postdoctoral Individual National Research Service [F32 HL152609]
The cardiac autonomic nervous system is crucial in cardiac physiology and disease, with therapies targeting the cardiac neuraxis showing promising results in pre-clinical and clinical studies.
The cardiac autonomic nervous system (ANS) plays an integral role in normal cardiac physiology as well as in disease states that cause cardiac arrhythmias. The cardiac ANS, comprised of a complex neural hierarchy in a nested series of interacting feedback loops, regulates atrial electrophysiology and is itself susceptible to remodelling by atrial rhythm. In light of the challenges of treating atrial fibrillation (AF) with conventional pharmacologic and myoablative techniques, increasingly interest has begun to focus on targeting the cardiac neuraxis for AF. Strong evidence from animal models and clinical patients demonstrates that parasympathetic and sympathetic activity within this neuraxis may trigger AF, and the ANS may either induce atrial remodelling or undergo remodelling itself to serve as a substrate for AF. Multiple nexus points within the cardiac neuraxis are therapeutic targets, and neuroablative and neuromodulatory therapies for AF include ganglionated plexus ablation, epicardial botulinum toxin injection, vagal nerve (tragus) stimulation, renal denervation, stellate ganglion block/resection, baroreceptor activation therapy, and spinal cord stimulation. Pre-clinical and clinical studies on these modalities have had promising results and are reviewed here.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据